Feasibility of Continuous Monitoring of Endoscopy Performance and Adverse Events: A Single-Center Experience

Simple Summary The endoscopic diagnosis and treatment of (pre-)malignant lesions play a central role in gastrointestinal oncology. The procedures can be high-risk, and a substantial proportion of patients have multiple co-morbidities. While the quality and safety of gastrointestinal endoscopy could be improved through the continuous monitoring of adverse events and performance measures, such monitoring, although recommended by various professional societies, is not yet established in clinical practice. We began a prospective monitoring system at our endoscopy unit in 2018. This study aims to evaluate the quality of the documentation in order to validate the method via systematic review of the data collected at our center. Background: We integrated a standardized questionnaire focusing on adverse events and performance measures in gastrointestinal endoscopy as a mandatory component of the electronical medical record. Methods: This retrospective study was conducted using prospectively collected data on quality parameters and adverse events (AEPM) for all diagnostic and therapeutic endoscopic procedures at our center between 2018 and 2020. Results: A total of 7532 consecutive endoscopic procedures were performed in 5035 patients. The proportion of high-risk examinations and high-risk patients was 20% and 23%, respectively. Severe adverse events (AEs, n = 21) occurred in 0.3% of procedures and significantly more often in patients with an ASA score > II (0.6%, p < 0.01). We observed no long-term morbidity after severe AEs. Mortality was 0.03% (n = 2). Following screening colonoscopy (n = 242), four endoscopists documented AEPM in more than 98% of the examinations. The cecal intubation rate was 97%, and the mean adenoma detection rate 60%. The quality of lavage was documented in 97% (rated as good in 70% and moderate in 24%). Conclusions: The risk of adverse events is significantly increased in patients with an ASA score > II, which should be considered when choosing treatment methods and precautionary measures. Continuous recording of AEPM can be effectively integrated into the clinical reporting process, enabling analysis of the data and feedback to be provided to endoscopists.

Automated summary

The endoscopic diagnosis and treatment of (pre-)malignant lesions in gastrointestinal oncology are important but high-risk procedures. Continuous monitoring of adverse events and performance measures is recommended but not yet established in clinical practice. This study aims to evaluate the quality of documentation and validate the method of monitoring at our hospital.